Reporting to the Head of US Patient Advocacy & Government Affairs, as the Sr. Director, US Policy Strategy, you will lead CSL’s US health policy and market access policy strategy, serving as the company’s principal US policy expert. You will assess legislative and regulatory developments, identify risks and opportunities, develop policy positions, and shape advocacy strategies that support CSL’s business, portfolio, pipeline, and patient access priorities. In this role, you will oversee the full range of federal and state policy issues affecting CSL, including drug pricing reform, government payer and reimbursement policy, 340B, PBM reform, intellectual property, trade, tax, and manufacturing and supply chain policy. You will partner across Government Affairs and Advocacy, Market Access, Legal, Commercial, Medical Affairs, Regulatory Policy, Communications, Finance, Manufacturing/Supply Chain, and US/global Therapeutic Area teams to translate complex policy issues into clear business implications and actionable strategies. You will also represent CSL with policymakers, government agencies, trade associations, industry coalitions, think tanks, and other external stakeholders.You will keep patients and plasma donors central to CSL’s policy work, advancing strategies that support access to innovative therapies, address unmet medical needs, and strengthen CSL’s portfolio across Immunology, Hematology, Cardiovascular and Metabolic, Transplant, and Respiratory.